• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Detection and separation of the anthrapyrazole CI-941 and its metabolites in serum and urine by high-performance liquid chromatography.

作者信息

Proksch B, Blanz J, Zeller K P, Ehninger G

机构信息

Medizinische Klinik and Poliklinik, Universität Tübingen, Germany.

出版信息

J Chromatogr B Biomed Appl. 1994 Aug 19;658(2):349-53. doi: 10.1016/0378-4347(94)00235-5.

DOI:10.1016/0378-4347(94)00235-5
PMID:7820263
Abstract

A high-performance liquid chromatographic method using ion-pairing chromatography on reversed-phase C18 material with a mobile phase of acetonitrile-water (19:81, v/v) containing 5 mM 1-pentanesulfonic acid was developed for the detection and separation of the anthrapyrazole CI-941 (I) and its metabolites. After sample clean-up with solid-phase extraction, I and its metabolites were measurable at a wavelength of 491 nm. A detection limit of 5 ng/ml was achievable for I. The dicarboxylic acid derivative and the isomers of the monocarboxylic acid derivative could be separated. Application of the method to a human pharmacokinetic study showed two and four metabolites of I in serum and urine respectively.

摘要

相似文献

1
Detection and separation of the anthrapyrazole CI-941 and its metabolites in serum and urine by high-performance liquid chromatography.
J Chromatogr B Biomed Appl. 1994 Aug 19;658(2):349-53. doi: 10.1016/0378-4347(94)00235-5.
2
Determination of the anthrapyrazole anticancer drug CI-941 in plasma and urine by solid-phase extraction and high-performance liquid chromatography.通过固相萃取和高效液相色谱法测定血浆和尿液中的蒽吡唑类抗癌药物CI-941。
J Chromatogr. 1989 Jun 30;491(1):253-61. doi: 10.1016/s0378-4347(00)82841-8.
3
High-performance liquid chromatographic assay for the experimental anticancer agent oxantrazole.
J Chromatogr. 1987 Aug 7;419:225-32. doi: 10.1016/0378-4347(87)80280-3.
4
Detection and separation of mitoxantrone and its metabolites in plasma and urine by high-performance liquid chromatography.高效液相色谱法检测和分离血浆及尿液中的米托蒽醌及其代谢产物
J Chromatogr. 1985 Jul 12;342(1):119-27. doi: 10.1016/s0378-4347(00)84494-1.
5
High-performance liquid chromatographic analysis of the anticancer drug oxantrazole in rat whole blood and tissues.
J Chromatogr. 1992 Nov 6;582(1-2):225-31. doi: 10.1016/0378-4347(92)80323-i.
6
Detection and identification of human urinary metabolites of biantrazole (CI-941).
Drug Metab Dispos. 1993 Sep-Oct;21(5):955-61.
7
Elimination pathways of [14C]losoxantrone in four cancer patients.[14C]洛索蒽醌在四名癌症患者体内的消除途径。
Drug Metab Dispos. 2001 Feb;29(2):96-9.
8
Ion-paired high-performance liquid chromatographic determination of mitoxantrone in physiological fluids.离子对高效液相色谱法测定生理体液中的米托蒽醌
J Chromatogr. 1985 Jan 11;337(1):73-80. doi: 10.1016/0378-4347(85)80009-8.
9
Development of a radioimmunoassay for the anthrapyrazole chemotherapy agent CI-937 and the pharmacokinetics of CI-937 in rats.蒽吡唑化疗药物CI-937放射免疫分析法的建立及CI-937在大鼠体内的药代动力学研究
Cancer Res. 1989 Oct 1;49(19):5345-51.
10
Identification of two regioisomeric monocarboxylic acid metabolites of losoxantrone (DuP 941; Biantrazole) excreted in human urine.
Drug Metab Dispos. 1995 May;23(5):600-2.